• CLSI I/LA30-A

CLSI I/LA30-A

Immunoassay Interference by Endogenous Antibodies; Approved Guideline, ILA30AE

Clinical and Laboratory Standards Institute , 02/01/2008

Publisher: CLSI

File Format: PDF

$102.00$205.84


Clinical and Laboratory Standards Institute document I/LA30-A—Immunoassay Interference by Endogenous Antibodies; Approved Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

CLSI I/LA30-A History

CLSI I/LA30-A

CLSI I/LA30-A

$102.00 $205.84

CLSI I/LA30-P

CLSI I/LA30-P

$127.00 $255.27

More CLSI Standards PDF

CSA B125.1-12/ASME A112.18.1-2012 (R2017)
CSA Z1002-12 (R2022)

CSA Z1002-12 (R2022)

$70.00 $141.00

CSA HGV 4.3-2012

CSA HGV 4.3-2012

$205.00 $411.00

CSA C22.2 No. 18.3-12 (R2022)